4 results match your criteria: "The No. 1 Hospital of China Medical University[Affiliation]"
J Neurosurg
June 2011
Department of Radiology, The No. 1 Hospital of China Medical University, Shenyang, China.
Object: In this paper, the authors' aim was to use CT perfusion imaging to evaluate the early changes in tumor microcirculation following radiosurgery in rat C6 brain gliomas.
Methods: C6 glioma cells were inoculated into the right caudate nucleus of 25 Wistar rats using a stereotactic procedure. Tumor-bearing rats were randomly divided into 2 groups (tumor group and treatment group).
Nucl Med Commun
August 2008
Nuclear Medicine Department, the No. 1 Hospital of China Medical University, Shenyang, Liaoning, China.
Objective: The aim of this study was to investigate the changes in early and late washout rates of 99mTc-methoxyisobutylisonitrile (MIBI) in hypertrophic cardiomyopathy (HCM), and to analyze the relationships between early and late washout rates and the hypertrophic thickness of left ventricular (LV) wall.
Methods: The patients who were clinically diagnosed as positive for HCM underwent 99mTc-MIBI static planar and gated single-photon emission computed tomography (SPECT) imaging. Early (90 min after the intravenous injection) and late (4 h after the intravenous injection) washout rates of 99mTc-MIBI between HCM group and normal control group were compared.
Zhonghua Er Ke Za Zhi
September 2007
Department of Pediatrics, The No.1 Hospital of China Medical University, Shenyang 110001, China.
Objective: Glucocorticoid (GC) has occupied a central role in the treatment of acute lymphoblastic leukemia due to its ability to induce apoptosis in neoplastic lymphoid cells. Glucocorticoid resistance is present among 20% initial acute lymphoblastic leukemia, even 80% refractory acute lymphoblastic leukemia. Glucocorticoid resistance has been an important determinant of clinical outcome.
View Article and Find Full Text PDFZhonghua Nan Ke Xue
July 2005
Department of Urology, the No. 1 Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Objective: To investigate the expression of TGF-beta1 mRNA in prostate carcinoma tissues and its significance.
Methods: RT-PCR method was used to examine the expression of TGF-beta1 mRNA in normal and carcinomatous prostate tissues.
Results: The relative content of TGF-beta1 mRNA of normal prostate tissues was (0.